31 Mar 2024
Assets17.56
Total Income17.43
EBITDA4.43
Profit After Tax2.96
NET Worth9.20
Reserves and Surplus1.29
Total Borrowing3.58
At a glance
Updated 2026-09-09The shares listed at ₹111.00, a 2.78% move from the issue price. Biopol Chemicals is a SME IPO with an issue size of ₹31.26 crore, proposed for listing on NSE SME. The offer opens on 6th Feb 2026 and closes on 10th Feb 2026. The issue structure includes a fresh issue of ₹29.63 crore. The current listing schedule points to 13th Feb 2026.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹31.26 Cr
Fresh issue₹29.63 Cr
Face value₹10
Price band₹102.00–₹108.00
Allotment11th Feb 2026
Listing13th Feb 2026
Listing performance
Full performance ↗Issue price₹108.00
Listing price₹111.00
Current price—
Listing gain2.78%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹1.00
GMP / upper price0.93%
Est. listing₹109.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens6th Feb 2026
Closes10th Feb 2026
Allotment11th Feb 2026
Refund12th Feb 2026
Demat12th Feb 2026
Listing13th Feb 2026
Subscription demand
Full bidding ↗QIB21.05×
sHNI18.48×
bHNI22.94×
NII / HNI22.94×
Retail20.80×
Total22.33×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Max) | 2 | 2400 | ₹259,200 |
| S-HNI (Min) | 3 | 3600 | ₹388,800 |
| S-HNI (Max) | 7 | 8400 | ₹907,200 |
| B-HNI (Min) | 8 | 9600 | ₹1,036,800 |
Company
Use of proceeds
| Object | Amount |
|---|---|
| Acquisition of industrial land | ₹12.26 Cr |
| Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies | ₹11.10 Cr |
| General Corporate Purposes | ₹4.04 Cr |
| Issue Expenses | ₹3.85 Cr |
| Total | ₹31.26 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue48.97₹ Cr · -0.4% vs prior year
EBITDA8.99₹ Cr · +37.7% vs prior year
PAT6.00₹ Cr · +38.6% vs prior year
Assets48.88₹ Cr · +55.3% vs prior year
Net Worth19.54₹ Cr · +44.4% vs prior year
Borrowing14.92₹ Cr · +94.0% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2025
Assets31.48
Total Income49.15
EBITDA6.53
Profit After Tax4.33
NET Worth13.53
Reserves and Surplus5.62
Total Borrowing7.69
31 Dec 2025
Assets48.88
Total Income48.97
EBITDA8.99
Profit After Tax6.00
NET Worth19.54
Reserves and Surplus11.63
Total Borrowing14.92
KPIs
| KPI | Mar 31, 2025 | Dec 31, 2025 |
|---|---|---|
| ROE | 38.10% | 36.32% |
| ROCE | 30.57% | 26.32% |
| Debt / Equity | 0.57% | 0.76% |
| RoNW | 32.00% | 30.74% |
| PAT Margin | 8.84% | 12.29% |
| EBITDA Margin | 13.30% | 18.41% |
| Price to Book Value | 6.31 | 4.37 |
Valuation & shareholding
Pre-IPO EPS5.47
Post-IPO EPS7.41
Pre-IPO P/E19.73
Post-IPO P/E14.58
Promoter holding pre89.88%
Promoter holding post65.81%
Market cap₹116.70 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Biopol Chemicals IPO | — | 14.58 x | — | — |
| Shanti Inorganic IPO | — | 16.63 x | — | — |
| Devson Catalyst IPO | — | 12.81 x | — | — |
| Sundrex Oil IPO | — | - | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| Acquisition of industrial land | ₹12.26 Cr |
| Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies | ₹11.10 Cr |
| General Corporate Purposes | ₹4.04 Cr |
| Issue Expenses | ₹3.85 Cr |
| Total | ₹31.26 Cr |
Registrar & lead managers
Registrar
Bigshare Services Pvt.Ltd.Lead managers
- Smart Horizon Capital Advisors...
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-09.
IPO UPDATE ALERTS
Register for IPO Updates →Track Biopol Chemicals without missing an update
Register for subscription, GMP, allotment and listing notifications.